Thiem D Phan
Examiner (ID: 7633)
Most Active Art Unit | 3729 |
Art Unit(s) | 3729 |
Total Applications | 2341 |
Issued Applications | 1787 |
Pending Applications | 105 |
Abandoned Applications | 401 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 13372819
[patent_doc_number] => 20180237950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => METHODS AND COMPOSITIONS FOR IN SILICO LONG READ SEQUENCING
[patent_app_type] => utility
[patent_app_number] => 15/553495
[patent_app_country] => US
[patent_app_date] => 2016-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34828
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15553495
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/553495 | Methods and compositions for sequencing | Feb 24, 2016 | Issued |
Array
(
[id] => 16563200
[patent_doc_number] => 10888547
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-12
[patent_title] => Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase
[patent_app_type] => utility
[patent_app_number] => 15/049946
[patent_app_country] => US
[patent_app_date] => 2016-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 18197
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15049946
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/049946 | Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase | Feb 21, 2016 | Issued |
Array
(
[id] => 16786390
[patent_doc_number] => 10988805
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-27
[patent_title] => Methods related to DNA sequencing
[patent_app_type] => utility
[patent_app_number] => 15/552040
[patent_app_country] => US
[patent_app_date] => 2016-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5355
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15552040
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/552040 | Methods related to DNA sequencing | Feb 18, 2016 | Issued |
Array
(
[id] => 16696621
[patent_doc_number] => 10947201
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Certain chemical entities, compositions, and methods
[patent_app_type] => utility
[patent_app_number] => 15/044966
[patent_app_country] => US
[patent_app_date] => 2016-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33477
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 241
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15044966
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/044966 | Certain chemical entities, compositions, and methods | Feb 15, 2016 | Issued |
Array
(
[id] => 11907032
[patent_doc_number] => 09775829
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-03
[patent_title] => 'Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto'
[patent_app_type] => utility
[patent_app_number] => 15/013057
[patent_app_country] => US
[patent_app_date] => 2016-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 43
[patent_no_of_words] => 84453
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15013057
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/013057 | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto | Feb 1, 2016 | Issued |
Array
(
[id] => 10797780
[patent_doc_number] => 20160143937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'METHODS OF USING CLEAVABLE DRUG CONJUGATES AND COMPOSITIONS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/011661
[patent_app_country] => US
[patent_app_date] => 2016-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44241
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15011661
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/011661 | METHODS OF USING CLEAVABLE DRUG CONJUGATES AND COMPOSITIONS THEREOF | Jan 31, 2016 | Abandoned |
Array
(
[id] => 11031458
[patent_doc_number] => 20160228414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-11
[patent_title] => 'MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS'
[patent_app_type] => utility
[patent_app_number] => 15/010542
[patent_app_country] => US
[patent_app_date] => 2016-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34321
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15010542
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/010542 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | Jan 28, 2016 | Abandoned |
Array
(
[id] => 15337637
[patent_doc_number] => 10524469
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Acetate derived compounds from geranylorcinol. synthesis process for obtaining said compounds and use of said compounds as antifungal against
[patent_app_type] => utility
[patent_app_number] => 15/546910
[patent_app_country] => US
[patent_app_date] => 2016-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4347
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15546910
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/546910 | Acetate derived compounds from geranylorcinol. synthesis process for obtaining said compounds and use of said compounds as antifungal against | Jan 24, 2016 | Issued |
Array
(
[id] => 10791444
[patent_doc_number] => 20160137599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-19
[patent_title] => '2-METHYLTHIOPYRROLIDINES AND THEIR USE FOR MODULATING BACTERIAL QUORUM SENSING'
[patent_app_type] => utility
[patent_app_number] => 15/000176
[patent_app_country] => US
[patent_app_date] => 2016-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16983
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15000176
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/000176 | 2-methylthiopyrrolidines and their use for modulating bacterial quorum sensing | Jan 18, 2016 | Issued |
Array
(
[id] => 11009641
[patent_doc_number] => 20160206594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'Pro-Neurogenic Compounds'
[patent_app_type] => utility
[patent_app_number] => 14/996596
[patent_app_country] => US
[patent_app_date] => 2016-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 50964
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14996596
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/996596 | Pro-neurogenic compounds | Jan 14, 2016 | Issued |
Array
(
[id] => 10774685
[patent_doc_number] => 20160120842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-05
[patent_title] => 'AMORPHOUS AND A CRYSTALLINE FORM OF GENZ 112638 HEMITARTRATE AS INHIBITOR OF GLUCOSYLCERAMIDE SYNTHASE'
[patent_app_type] => utility
[patent_app_number] => 14/994489
[patent_app_country] => US
[patent_app_date] => 2016-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 19181
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14994489
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/994489 | AMORPHOUS AND A CRYSTALLINE FORM OF GENZ 112638 HEMITARTRATE AS INHIBITOR OF GLUCOSYLCERAMIDE SYNTHASE | Jan 12, 2016 | Abandoned |
Array
(
[id] => 10785802
[patent_doc_number] => 20160131958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-12
[patent_title] => 'SURFACTANTS WITH A TERMINAL DIALKYL- OR CYCLOALKYL-SUBSTITUTED TERTIARY AMINE AND INKS INCLUDING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/988442
[patent_app_country] => US
[patent_app_date] => 2016-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5378
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14988442
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/988442 | SURFACTANTS WITH A TERMINAL DIALKYL- OR CYCLOALKYL-SUBSTITUTED TERTIARY AMINE AND INKS INCLUDING THE SAME | Jan 4, 2016 | Abandoned |
Array
(
[id] => 10761872
[patent_doc_number] => 20160108025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-21
[patent_title] => 'POLYCYCLIC HERG ACTIVATORS'
[patent_app_type] => utility
[patent_app_number] => 14/983741
[patent_app_country] => US
[patent_app_date] => 2015-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44120
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14983741
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/983741 | POLYCYCLIC HERG ACTIVATORS | Dec 29, 2015 | Abandoned |
Array
(
[id] => 12120125
[patent_doc_number] => 20180003711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'DIRECTED EVOLUTION OF MEMBRANE PROTEINS IN EUKARYOTIC CELLS WITH A CELL WALL'
[patent_app_type] => utility
[patent_app_number] => 15/538479
[patent_app_country] => US
[patent_app_date] => 2015-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 15927
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15538479
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/538479 | DIRECTED EVOLUTION OF MEMBRANE PROTEINS IN EUKARYOTIC CELLS WITH A CELL WALL | Dec 20, 2015 | Abandoned |
Array
(
[id] => 13537389
[patent_doc_number] => 20180320241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-08
[patent_title] => METHODS FOR IDENTIFYING MULTIPLE EPITOPES IN SELECTED SUB-POPULATIONS OF CELLS
[patent_app_type] => utility
[patent_app_number] => 15/525876
[patent_app_country] => US
[patent_app_date] => 2015-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20913
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15525876
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/525876 | METHODS FOR IDENTIFYING MULTIPLE EPITOPES IN SELECTED SUB-POPULATIONS OF CELLS | Dec 20, 2015 | Abandoned |
Array
(
[id] => 12030757
[patent_doc_number] => 20170320856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'AMIDOETHYL AZOLE OREXIN RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 15/535271
[patent_app_country] => US
[patent_app_date] => 2015-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18211
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15535271
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/535271 | Amidoethyl azole orexin receptor antagonists | Dec 17, 2015 | Issued |
Array
(
[id] => 12526662
[patent_doc_number] => 10005730
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-26
[patent_title] => 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor
[patent_app_type] => utility
[patent_app_number] => 14/969454
[patent_app_country] => US
[patent_app_date] => 2015-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7419
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14969454
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/969454 | 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor | Dec 14, 2015 | Issued |
Array
(
[id] => 10750701
[patent_doc_number] => 20160096852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-07
[patent_title] => 'Synthesis of 4-(pentafluorosulfanyl)benzenediazonium tetrafluoroborate and Analogs'
[patent_app_type] => utility
[patent_app_number] => 14/966769
[patent_app_country] => US
[patent_app_date] => 2015-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18060
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14966769
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/966769 | Synthesis of 4-(pentafluorosulfanyl)benzenediazonium tetrafluoroborate and analogs | Dec 10, 2015 | Issued |
Array
(
[id] => 10750675
[patent_doc_number] => 20160096824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-07
[patent_title] => 'Heterocyclic Compounds Useful for Kinase Inhibition'
[patent_app_type] => utility
[patent_app_number] => 14/965334
[patent_app_country] => US
[patent_app_date] => 2015-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26186
[patent_no_of_claims] => 82
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14965334
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/965334 | Heterocyclic compounds useful for kinase inhibition | Dec 9, 2015 | Issued |
Array
(
[id] => 10737189
[patent_doc_number] => 20160083339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-24
[patent_title] => 'TUNABLE NITRIC OXIDE-RELEASING MACROMOLECULES HAVING MULTIPLE NITRIC OXIDE DONOR STRUCTURES'
[patent_app_type] => utility
[patent_app_number] => 14/961133
[patent_app_country] => US
[patent_app_date] => 2015-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12556
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14961133
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/961133 | Tunable nitric oxide-releasing macromolecules having multiple nitric oxide donor structures | Dec 6, 2015 | Issued |